IL10 and amyotrophic lateral sclerosis: Future studies using combinatorial infusions of these biologics (Il-10 in combination with scavenger receptors) into various ALS rodent models at different stages of the disease will need to be done to establish the potential translatability of such anti-inflammatory therapeutic combinations in ALS and related disorders.